Bravelle Related Published Studies
Well-designed clinical trials related to Bravelle (Urofollitropin)
Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulation. [2009.04]
Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and Bravelle for controlled ovarian hyperstimulation. [2008.03.25]
Evaluation of mixed protocols with Bravelle (human-derived FSH) and Repronex (hMG) to assess clinical efficacy (EMBRACE) in women undergoing in vitro fertilization. [2004.08]
Highly purified human-derived follicle-stimulating hormone (Bravelle) has equivalent efficacy to follitropin-beta (Follistim) in infertile women undergoing in vitro fertilization. [2003.10.03]
Comparison of the efficacy and safety of a highly purified human follicle-stimulating hormone (Bravelle) and recombinant follitropin-beta for in vitro fertilization: a prospective, randomized study. [2002.06]
Well-designed clinical trials possibly related to Bravelle (Urofollitropin)
Prospective, randomized study comparing highly purified urinary follicle-stimulating hormone (FSH) and recombinant FSH for in vitro fertilization/intracytoplasmic sperm injection in patients with polycystic ovary syndrome. [2010.11]
Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial. [2009.04]
Efficacy of a combined protocol of urinary and recombinant follicle-stimulating hormone used for ovarian stimulation of patients undergoing ICSI cycle. [2007.09]
Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial. [2007.07]
Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis. [2006.07.18]
Urinary follicle-stimulating hormone (FSH) is more effective than recombinant FSH in older women in a controlled randomized study. [2006.05]
Effect of highly purified urinary follicle-stimulating hormone on oocyte and embryo quality. [2002.11]
Concentrations of insulin-like growth factor (IGF)-I and IGF binding protein-3 in the follicular fluid of women undergoing ovarian hyperstimulation with different gonadotropin preparations. [2001.12]
Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group. [1998.01]
Other research related to Bravelle (Urofollitropin)
Mixed protocols: multiple ratios of FSH and LH bioactivity using highly purified, human-derived FSH (BRAVELLE) and highly purified hMG (MENOPUR) are unaltered by mixing together in the same syringe. [2005.11.09]
Urofollitropin and ovulation induction. [2005]
Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP). [2000.05]
Outcome comparison of in vitro fertilization treatment with highly purified subcutaneous follicle-stimulating hormone (Fertinex, a urofollitropin) versus intramuscular menotropins. [1998.08]
Serum FSH levels in women with polycystic ovary syndrome during ovulation induction using down-regulation and urofollitropin. [1997.05]
Serum levels of luteinizing and follicle-stimulating hormones in normal and poor-responding patients undergoing ovarian stimulation with urofollitropin after pituitary downregulation. [1997.02]
Use of recombinant human follicle-stimulating hormone for in vitro fertilization-embryo transfer after severe systemic immunoglobulin E-mediated reaction to urofollitropin. [1996.07]
Use of follicle-stimulating hormone alone (urofollitropin) to stimulate the ovaries for assisted conception after pituitary desensitization. [1994.11]
Other possibly related research studies
A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data. [2005.03]
Follicle-stimulating hormone in clinical practice: an update. [2004]
Infertility in women: an update. [1998.07]
The performance of subcutaneously injected Fertinex when used as the sole gonadotropin for in vitro fertilization stimulation. [1998.04]
Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. [1998.03]
Follicle stimulating hormone effects on immature human oocytes: in vitro maturation and hormone production. [1997.04]
Human follicular fluid levels of endothelins in relation to oocyte maturity status. [1996]
Increase in androgen:estrogen ratio specifically during low-dose follicle-stimulating hormone therapy for polycystic ovary syndrome. [1995.10]
Evolving patterns of iatrogenic multifetal pregnancy generation: implications for aggressiveness of infertility treatments. [1995.06]
Use of fertility drugs in the United States, 1973 through 1991. [1993.12]
Pharmacokinetics of recombinant human follicle stimulating hormone after intravenous, intramuscular, and subcutaneous administration in monkeys, and comparison with intravenous administration of urinary follicle stimulating hormone. [1993.01]
Beneficial effects of a higher starting dose of gonadotrophins in some poor responders. [2006.09]
Gonadotrophin products: empowering patients to choose the product that meets their needs. [2007.07]
Risk factors for ovarian hyperstimulation syndrome in Thai patients using gonadotropins for in vitro fertilization. [2008.06.15]
Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate. [2008.06]
Prospective, randomized study comparing highly purified urinary
follicle-stimulating hormone (FSH) and recombinant FSH for in vitro
fertilization/intracytoplasmic sperm injection in patients with polycystic ovary
syndrome. [2010]
|